UysalOKSahinDYDuranM, et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology. 2014;65(3):227–231.
2.
SchaperW. Tangential wall stress as a molding force in the development of collateral vessels in the canine heart. Experientia. 1967;23(7):595–596.
3.
FujitaMSasayamaSOhnoANakajimaHAsanoiH. Importance of angina for development of collateral circulation. Br Heart J. 1987;57(2):139–143.
4.
HabibGBHeibigJFormanSA. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83(3):739–746.
5.
WilliamsDOAmsterdamEAMillerRRMasonDT. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol. 1976;37(3):345–351.
6.
KatsikiNKaragiannisAAthyrosVGMikhailidisDP. Hyperuricaemia: more than just a cause of gout?J Cardiovasc Med (Hagerstown). 2013;14(6):397–402.
7.
FeigDIKangDHJohnsonRJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821.
8.
SundströmJSullivanLD'AgostinoRBLevyDKannelWBVasanRS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28–33.
9.
DuranMOrnekEMuratSN. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2012;63(6):472–475.
10.
FangJAldermanMH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404–2410.
11.
CulletonBFLarsonMGKannelWBLevyD. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131(1):7–13.
12.
PalmerTMNordestgaardBGBennM. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262.
13.
KrishnanESvendsenKNeatonJDGranditsGKullerLH. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008;168(10):1104–1110.
14.
KimTSPaeCUYoonSJ. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21(4):344–348.
